AndrewMills

Oversold, Lots of Cash, Great Partners, Falling Wedge

Long
NASDAQ:CRIS   Curis, Inc.
This stock is ASKING for a pop on the chart. Falling wedge, lots of cash, great partners in Roche and Genentech, FDA approved drug, actual REVs and a solid balance sheet... long and strong at this price... $1.33
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.